
AvoMD
Personalized medical guidelines | avoMD | United States.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
* | $5.0m | Seed | |
Total Funding | 000k |
Related Content
AvoMD, founded in 2020, is a New York-based company operating in the health technology sector, providing a clinical decision support platform for healthcare professionals. The company was established by a team of physicians, Dr. Joongheum Park (PJ), Dr. Yair Saperstein, and Laurence Coman, who experienced firsthand the challenges of clinician burnout and the difficulty of accessing critical medical information within the workflow. Dr. Park, a self-taught software developer and practicing internist, was overwhelmed by the volume of knowledge required for quality care and began creating his own software to streamline the clinical workflow. He teamed up with Dr. Saperstein, who had similar frustrations with clinical pathways from his experience as Chief Resident during the COVID-19 pandemic in Brooklyn and leading EHR implementations. Laurence Coman, with a background in software investing and whose parents are both physicians, joined them to round out the founding team with business strategy expertise.
The company's core offering is a no-code, AI-enabled platform that allows healthcare organizations, including hospitals and ambulatory practices, to transform their clinical guidelines, protocols, and pathways into interactive, actionable applications. This platform integrates directly into major Electronic Health Record (EHR) systems like Epic and MEDITECH, or can be used as a standalone web or mobile application. AvoMD's business model is subscription-based, priced per provider with various tiers available. The platform is designed to reduce the cognitive load on clinicians by simplifying tasks such as pre-charting, care planning, ordering, and documentation. It provides tools like "Ask Avo," an AI consult tool that answers patient-specific questions using EHR data and guidelines, and an AI Scribe that generates documentation from real-time patient-provider interactions. Randomized control trials and live deployments have demonstrated that the platform can save clinicians over 50% of their time in decision-making while improving patient outcomes.
AvoMD has secured a total of $11.1 million in funding over two seed rounds. A significant round in June 2023 raised $5 million, led by AlleyCorp with participation from other venture funds and notable angel investors. This funding is intended to fuel the platform's growth and expansion. The company has established partnerships with over 10 hospital systems, including Children's Minnesota and Ozarks Healthcare, and works with life sciences companies and medical societies to digitize guidelines. A key differentiator is its "Builder" feature, a drag-and-drop interface that enables clinical experts without programming experience to create and customize their own decision-support tools, ensuring that the content remains current and specific to the institution's needs without relying heavily on IT resources.
Keywords: clinical decision support, healthcare AI, no-code platform, EHR integration, physician burnout, clinical workflow automation, evidence-based medicine, point-of-care technology, digital health, medical guidelines, care pathways, clinical documentation, MedTech, health informatics, AI scribe, clinical intelligence, hospital software, ambulatory care technology, medical application builder, patient outcomes improvement